Supplementary Figure 2.
Three PDCs used in PDX models were selected for drug treatment.
Three patient-derived primary cells (14GS-076, 14GS-084, and 15GS-023) that were maintained in mice were selected for evaluating the anticancer effect of certain drugs. These PDXs maintained expression of CDK4 and MDM2 in their tumor tissues.